All studies
RecruitingOBSERVATIONAL

Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus

Researchers are studying specific immune cells, called Natural Killer T cells (iNKT cells), and proteins in people with lupus. They are looking at how a protein called FcRn and other similar proteins are found on these cells. The study compares people with active or newly diagnosed lupus to those whose lupus is inactive. By studying these cells, especially iNKT cells and monocytes, we hope to better understand how lupus affects the body and why it causes symptoms. This research could help in developing new treatments for autoimmune diseases, including lupus, by clarifying the role these immune players have in managing the condition.

At a glance

Status
Recruiting
Sponsor
University Hospital, Tours
Enrolment target
50
Start
21 Jul 2023
Estimated completion
01 Jul 2030

What is this study about?

Imagine your body's immune system as a team of defenders. In lupus, sometimes these defenders get confused and start attacking healthy parts of your own body. This study wants to understand more about specific members of this team, called 'Natural Killer T cells' (don't worry about the tricky name, just think of them as a type of immune cell) and another type, 'monocytes'. We're also looking at certain proteins that act like sensors on the surface of these cells, especially one called FcRn, and others named Fc gamma Receptors.

Researchers believe that these cells and their sensors play an important role in how lupus develops and behaves. For example, the FcRn protein can help manage antibodies, which are special proteins our immune system makes. In lupus, some of these antibodies mistakenly attack the body. Understanding how FcRn works might show us new ways to control these 'misbehaving' antibodies. We're interested in whether the numbers or activity of these cells and proteins change when lupus is active compared to when it's quiet.

By comparing blood samples from people with active lupus, newly diagnosed lupus, and inactive lupus, we hope to gain clearer insights. This research is important because the more we understand about what causes lupus and how it affects the body, the better we can develop new and more effective treatments. It's like finding missing pieces of a puzzle to get a complete picture of the disease.

Key takeaways

  • This study aims to understand lupus better by looking at immune cells.
  • It involves giving an extra part of a routine blood sample.
  • It's for adults diagnosed with systemic lupus.
  • Participation will not change your current medical care.
  • Your contribution helps research, but offers no direct personal benefit.

Who may be eligible?

This study is looking for adults aged 18 or older who have been diagnosed with systemic lupus. This includes people who have just found out they have lupus, or those who have had it for a while, whether their lupus is active or currently well-controlled.

You might be able to join if your doctor thinks you need a routine blood test for your lupus care, as the blood sample for the study will be taken at the same time.

However, you can't take part if you primarily have another autoimmune condition apart from lupus, or if you are under legal protection that prevents you from making decisions about research. You also cannot participate if you don't wish for your data to be used for the study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Have you been diagnosed with systemic lupus?
  3. Do you need a blood test for routine lupus check-ups?
  4. Do you agree that your de-identified data can be used for research?
Answer every question to see your result.

What does participation involve?

Taking part in this study would involve giving an extra blood sample at the same time as any routine blood tests your doctor might order for your lupus care. You won't need to visit the hospital just for the study, and there are no extra appointments or medications involved. The study simply uses a small amount of blood from a sample you would be giving anyway. There is no specific duration for your direct involvement beyond that single blood draw.

Potential risks and benefits

There are no significant direct benefits to you by taking part in this study, but your contribution will help scientists learn more about lupus, which could lead to better treatments for others in the future. The risks are very low, as it only involves an extra blood collection from a sample you're already giving. Like with any blood test, there's a very small chance of bruising or discomfort at the site where the blood is taken. You are free to change your mind and withdraw from the study at any time without it affecting your usual care.

Locations (1)

  • University Hospital
    Verified postcode
    Tours, France· Recruiting

Common questions

What is systemic lupus erythematosus?

It's an autoimmune disease where your body's immune system mistakenly attacks healthy tissues, causing inflammation and damage.

What is an 'immune cell'?

These are special cells in your body that help fight off infections and diseases. In lupus, sometimes they don't work quite right.

Will taking part affect my lupus treatment?

No, joining this study will not affect your current lupus treatment or your usual medical care in any way.

Do I need to do anything special?

The only thing you would do is allow scientists to use a small extra part of a blood sample you're already giving for another reason.

How will my personal information be kept private?

All your information will be handled confidentially, and your name will not be linked to the study results.

How to find out more

Yanis RAMDANI

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Study of Neonatal IgG Fc Receptor Expression in Natural Kill…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.